Second Quarter 2026
Filed Aug 10, 2026FutureFuel Announces Second Quarter 2026 Results
Revenue increased 120.7%, the Company reported net income of $11.4 million versus a net loss of ($14.2) million, and both Chemicals and Biofuels reported positive gross profit. The release also identifies significant derivative-related benefits and continued elevated input costs.
Key metrics
as reported| Metric | Value | q/q | y/y |
|---|---|---|---|
| Total revenueGAAP | $78.7 million | – | 120.7% |
| Total volume growthother | 40.4% | – | – |
| Average blended price increaseother | 80.2% | – | – |
| Total gross profitGAAP | $15.0 million | – | – |
| Net incomeGAAP | $11.4 million | – | +$25.6 million |
| Diluted earnings per shareGAAP | $0.25 per diluted share | – | – |
| Adjusted EBITDAnon-GAAP | $11.8 million | – | +$23.2 million |
| Chemicals gross profitGAAP | $5.0 million | – | – |
| Chemicals capacity utilizationother | 65% | – | – |
| Biofuels gross profitGAAP | $10.1 million | – | – |
| Biofuels capacity utilizationother | 56% | – | – |
| Net cash flow from operationsGAAP | $18.8 million | – | – |
Segments
| Segment | Revenue | q/q | y/y |
|---|---|---|---|
| ChemicalsThe increase was primarily driven by a 49% increase in volume/product mix effects and a 6% benefit from higher average prices. | $25.8 million | – | 55.5% |
| Custom ChemicalHigher volumes of products sold to energy customers. | $18.5 million | – | 30% |
| Performance ChemicalIncreased volumes for a new customer that began production during the fourth quarter of 2025. | $7.3 million | – | 209% |
| BiofuelsIncreased regulatory clarity surrounding the Clean Fuel Production Credit and record-high renewable volume obligation levels. | $52.9 million | – | 178% |
Full-year 2026 outlook
- NoteAnticipate positive Adjusted EBITDA in full-year 2026, excluding non-cash derivative timing differences related to changes in physical commodity prices.
- NoteThird quarter production rates are expected to exceed second quarter levels.
- NoteDuring the second half of 2026, the Company expects to receive $22 million in gross proceeds from the monetization of credits, including approximately $3 million in the third quarter and $19 million in the fourth quarter.
- NoteSales volumes are expected to further improve during the second half of 2026 given improved regulatory clarity.
- NoteInput costs for soybean oil and other raw materials used in the production of biofuels remain elevated, which is expected to have a continued, near-term impact on Biofuels gross profit per gallon sold.
What drove it
- Higher throughputs, an improved revenue mix, and higher average pricing in both the Chemical and Biofuel segments drove total revenue growth.
- Total production increased 26% on a year-over-year basis.
- Chemicals production increased 34% year-over-year, supported by demand across energy and industrial end-markets.
- Biofuels production increased 21% year-over-year despite a more than three-week biodiesel plant outage.
- The Company increased total Chemicals production capacity by 12% during the last twelve months.
- Second-quarter gross profit included $9.1 million related to the sale of physical inventory at prices above hedged levels and unrealized derivative gains of $3.2 million.
Concerns
- Second-quarter gross profit benefited from $9.1 million related to physical inventory sold at prices above hedged levels and $3.2 million of unrealized derivative gains.
- The Company stated that elevated input costs have partially offset the favorable pricing environment for finished Biofuels products and are expected to continue to affect Biofuels gross profit per gallon sold in the near term.
- Biofuels experienced a more than three-week biodiesel plant outage during the quarter.
- The management-commentary summary says Chemicals gross profit was $5.0 million versus $1.1 (3) million in the year-ago period, while the Chemicals segment section reports $5.0 million versus $3.8 million.
What to watch
- Whether third-quarter Biodiesel production rates exceed second-quarter levels.
- Whether Biofuels sales volumes improve during the second half of 2026 as regulatory clarity improves.
- The receipt of approximately $3 million in third-quarter and $19 million in fourth-quarter gross proceeds from monetization of credits.
- The effect of elevated soybean oil and other raw-material costs on Biofuels gross profit per gallon sold.
- Whether increased Chemicals capacity and 65% capacity utilization produce further operating leverage.
Balance sheet and cash flow
- Total cash and equivalents of $34.3 million as of June 30, 2026, up from $22.4 million at March 31, 2026.
- $35 million revolving credit facility with no outstanding borrowings.
- Net cash flow from operations was $18.8 million in the second quarter of 2026, compared to $5.2 million in the prior-year period.
- The Company secured a four-year agreement with a third-party to monetize Section 45Z Clean Fuel Production and Small Producer Tax Credits.
- The Company expects to receive $22 million in gross proceeds from the monetization of credits during the second half of 2026, including approximately $3 million in the third quarter and $19 million in the fourth quarter.
Analysis
FutureFuel reported a substantial second-quarter turnaround. Total revenue was $78.7 million, up 120.7% from $35.7 million, while total gross profit was $15.0 million versus a gross loss of ($12.4) million. The Company reported net income of $11.4 million, compared with a net loss of ($14.2) million, and Adjusted EBITDA of $11.8 million compared with ($11.4) million. Management attributed the revenue increase to higher throughputs, improved mix, and higher average pricing in both operating segments.
Chemicals revenue increased to $25.8 million, with Custom Chemical revenue of $18.5 million and Performance Chemical revenue of $7.3 million. Demand from energy customers and volumes from a customer that began production in the fourth quarter of 2025 were the stated contributors. Chemicals capacity utilization improved to 65% from 54%, and the Company said total Chemicals production capacity increased by 12% during the last twelve months. The detailed segment discussion reported Chemicals gross profit of $5.0 million versus $3.8 million.
Biofuels revenue increased to $52.9 million from $19.1 million, and gross profit was $10.1 million versus a gross loss of ($13.5) million. Management cited regulatory clarity surrounding the Clean Fuel Production Credit and record-high renewable volume obligation levels, along with higher sales volumes and pricing realization. Biofuels production increased 21% year-over-year despite a more than three-week biodiesel plant outage, and capacity utilization reached 56%. Elevated soybean oil and other input costs remain a stated near-term constraint on Biofuels gross profit per gallon sold.
Profitability also reflected material hedging and derivative effects. Second-quarter gross profit benefited by $9.1 million from physical inventory sold at prices above hedged levels, which the Company said fully offset realized derivative losses of ($9.1) million recognized in the first quarter of 2026. Gross profit also benefited from unrealized derivative gains of $3.2 million. Management explicitly characterized the full-year Adjusted EBITDA objective as excluding non-cash derivative timing differences related to physical commodity-price changes.
Liquidity increased during the quarter. The financial-resources section reported total cash and equivalents of $34.3 million at June 30, 2026, compared with $22.4 million at March 31, 2026, alongside a $35 million revolving credit facility with no outstanding borrowings. Net cash flow from operations was $18.8 million versus $5.2 million in the prior-year period. The Company expects $22 million in gross proceeds from credit monetization during the second half of 2026 and continues to anticipate positive Adjusted EBITDA for full-year 2026, but it provided no quantitative revenue, margin, expense, or tax-rate outlook.
Management, verbatim
The second quarter marked a return to profitable growth for FutureFuel, a performance driven by strengthening end-market demand, improved production economics, continued cost discipline, and enhanced optimization of our Batesville plant.
Roeland Polet, Chairman and Chief Executive Officer of FutureFuel
While our second quarter results include a timing benefit related to ongoing biofuels hedging activity, our core business performed well in the period, delivering its strongest financial performance since the fourth quarter of 2024.
Roeland Polet, Chairman and Chief Executive Officer of FutureFuel
During the second half of 2026, we expect to receive $22 million in gross proceeds from the monetization of credits, including approximately $3 million in the third quarter and $19 million in the fourth quarter.
Rose Sparks, Chief Financial Officer
Not in the filing
stated, not guessed- GAAP operating income and prior-year comparison were not provided in the supplied text.
- GAAP operating margin and gross margin were not provided in the supplied text.
- Non-GAAP earnings per share was not provided in the supplied text.
- Prior-year diluted earnings per share was not provided in the supplied text.
- Free cash flow was not provided in the supplied text.
- Capital-return activity, including share repurchases and dividends, was not provided in the supplied text.
- Debt balance other than no outstanding borrowings on the revolving credit facility was not provided in the supplied text.
- Capital-expenditure period comparison was not available because the supplied filing text is truncated after the beginning of the capital-expenditures sentence.
- Quantitative full-year revenue, gross-margin, operating-expense, and tax-rate guidance were not provided.
- Previous-quarter outlook was not provided.
- The CFO commentary states total cash of $34.4 million at the end of the second quarter, while the financial-resources section states total cash and equivalents of $34.3 million as of June 30, 2026.
AlphaAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.